Risk factors for the development and progression of carcinoid heart disease

American Journal of Cardiology

Volumn 107, Issue 8, 2011, Pages 1221-1226

  Bhattacharyya, Sanjeev ^a   Toumpanakis, Christos ^a   Chilkunda, Deepika ^a   Caplin, Martyn Evan ^a   Davar, Joseph ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID;

ADULT; AGED; ARTICLE; CARCINOID SYNDROME; CARDIOVASCULAR RISK; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

AGED; CARCINOID HEART DISEASE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYDROXYINDOLEACETIC ACID; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953232974     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.12.025     Document Type: Article

References (25)

1. I.M. Modlin, K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, R.V. Thakker, M. Caplin, G. Delle Fave, G.A. Kaltas, E.P. Krenning, S.F. Moss, O. Nilsson, G. Rindi, R. Salazar, P. Ruszniewski, and A. Sundin Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 2008 61 72
2. M.H. Kulke, and R.J. Mayer Carcinoid tumours N Engl J Med 240 1999 858 868
3. S. Bhattacharyya, J. Davar, G. Dreyfus, and M.E. Caplin Carcinoid heart disease Circulation 116 2007 2860 2865 (Pubitemid 350301147)
4. P.A. Pellikka, A.J. Tajik, B.K. Khandheria, J.B. Seward, J.A. Callahan, H.C. Pitot, and L.K. Kvols Carcinoid heart disease Clinical and echocardiographic spectrum in 74 patients Circulation 87 1993 1188 1196 (Pubitemid 23110391)
5. P. Robiolio, V. Rigolin, J. Wilson, J.K. Harrison, L.L. Sanders, T.M. Bashmore, and J.M. Feldman Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterisation and echocardiography Circulation 92 1995 790 795
6. J.E. Moller, H.M. Connolly, J. Rubin, J.B. Seward, K. Modesto, and P.A. Pellikka Factors associated with progression of carcinoid heart disease N Engl J Med 348 2003 1005 1015 (Pubitemid 36302245)
7. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, L. Rubinstein, J. Verweij, M. Van Glabbeke, A.T. van Oosterom, M.C. Christian, and S.G. Gwyther New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
8. B. Eriksson, G. Kloppel, E. Krenning, H. Ahlman, U. Plockinger, B. Wiedenmann, R. Arnold, C. Auernhammer, M. Korner, G. Rindi, S. Wildi All Other Frascati Consensus Conference Participants Consensus guidelines for the management of patients with digestive neuroendocrine tumorswell-differentiated jejunal-ileal tumor/carcinoma Neuroendocrinology 87 2008 8 19 (Pubitemid 350308290)
9. T. Steinmller, R. Kianmanesh, M. Falconi, A. Scarpa, B. Taal, D.J. Kwekkeboom, J.M. Lopes, A. Perren, G. Nikou, J. Yao, G.F. Delle Fave, D. O'Toole Frascati Consensus Conference Participants Consensus guidelines for the management of patients with liver metastases from digestive neuroendocrine tumors: foregut, midgut, hindgut, and unknown primary Neuroendocrinology 87 2008 47 62 (Pubitemid 350308294)
10. W. Zoghbi, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, C.D. Kraft, R.A. Levine, P. Nihoyannopoulos, C.M. Otto, M.A. Quinones, H. Rakowski, W.J. Stewart, A. Waggoner, and N.J. Weissman Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography J Am Soc Echocardiogr 1 2003 777 802 (Pubitemid 37391035)
11. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chambers, A. Evangelista, B.P. Griffin, B. Lung, C.M. Otto, P.A. Pellikka, and M. Quinones Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice J Am Soc Echocardiogr 1 2009 1 23
12. R. Lang, M. Bierig, R. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M. St John Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
13. W.D. Denney, W.E. Kemp, L.B. Anthony, J.A. Oates, and B.F. Byrd III Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease J Am Coll Cardiol 32 1998 1017 1022 (Pubitemid 28459594)
14. G.A. Kaltsas, G.M. Besser, and A.B. Grossman The diagnosis and medical management of advanced neuroendocrine tumors Endocr Rev 25 2004 458 511 (Pubitemid 38780668)
15. B.K. Eriksson, E.G. Larsson, B.M. Skogseid, A.M. Lofberg, L.E. Lorelius, and K.E. Oberg Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors Cancer 83 1998 2293 2301 (Pubitemid 28533498)
16. J.G. Drougas, L.B. Anthony, T.K. Blair, R.R. Lopez, J.K. Wright, W.C. Chapman, L. Webb, M. Mazer, S. Meranze, and C.W. Pinson Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors Am J Surg 175 1998 408 412 (Pubitemid 28213456)
17. J.R. Strosberg, J. Choi, A.B. Cantor, and L.K. Kvols Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors Cancer Control 13 2006 72 78 (Pubitemid 43327557)
18. E.T. Janson, and K. Oberg Long-term management of the carcinoid syndrome Treatment with octreotide alone and in combination with alpha-interferon Acta Oncol 32 1993 225 229 (Pubitemid 23188540)
19. J.B. Cwikla, A. Sankowski, N. Seklecka, J.R. Buscombe, A. Nasierowska-Guttmejer, K.G. Jeziorski, R. Mikolajczak, D. Pawlak, K. Stepien, and J. Walecki Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study Ann Oncol 21 2010 787 794
20. A.M. Bernheim, H.M. Connolly, J. Rubin, J.E. Møller, C.G. Scott, D.M. Nagorney, and P.A. Pellikka Role of hepatic resection for patients with carcinoid heart disease Mayo Clin Proc 83 2008 143 150 (Pubitemid 351303098)
21. J. Waltenberger, L. Lundin, K. Oberg, E. Willander, K. Miyazono, C.H. Heldin, and K. Funa Involvement of transforming growth factor in the formation of fibrotic lesions in carcinoid heart disease Am J Pathol 142 1993 71 78 (Pubitemid 23026911)
22. B. Gustafsson, K. Tommeras, I. Nordrum, J.P. Loennechen, A. Brunsvik, E. Solligard, R. Fossmark, I. Bakke, U. Syverson, and H. Waldum Long-term serotonin administration induces heart valve disease in rats Circulation 111 2005 1517 1522 (Pubitemid 40470647)
23. A.I. Vinik, M.P. Silva, G. Woltering, V.L. Go, R. Warner, and M. Caplin Biochemical testing for neuroendocrine tumors Pancreas 38 2009 876 889
24. L. Lundin, I. Norheim, J. Landelius, K. Oberg, and E. Theodorsson-Norheim Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities Circulation 77 1988 264 269 (Pubitemid 18060033)
25. J. Nilsson, A.M. von Euler, and C.J. Dalsgaard Stimulation of connective tissue cell growth by substance P and substance K Nature 315 1985 61 63 (Pubitemid 15064899)